Did You Know...
...that two musicians were responsible for the invention of color print film? Fascinated by photography, Leopold Godowsky and Leopold Mannes worked together to produce an easy-to-use, practical color film. They worked full time as music teachers and gave concerts while experimenting during their off hours in Mannes' kitchen. Their success earned them full-time, well-paying jobs at Kodak and their efforts resulted in Kodachrome film, which was introduced in 1935.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7351723 | Freeze-dried pantoprazole preparation and pantoprazole injection Lyophilized pantoprazole preparations which are obtainable by freeze-drying of an aqueous solution of pantoprazole, ethylenediamine tetraacetic acid and/or a suitable salt thereof, and sodium hydroxide and/or sodium carbonate are disclosed. The preparations have adv... | 04/01/2008 |
| 7291353 | Anti-peptic ulcer activity of an extract of a flower of A pharmaceutical composition comprising an effective amount of an extract or lyophilized extract or at least one bioactive fraction obtained from the plant Woodfordia fruticosa along with one or more pharmaceutically acceptable additives/carriers for treating... | 11/06/2007 |
| 6949519 | Macrolide solvates Azithromycin in the form of a monohydrate comprising from 4.0% to 6.5% of water, a process for its preparation and its use in pharmaceutical compositions. ... | 09/27/2005 |
| 6855347 | Composition for treating gastric ulcer and a process for preparing the same The present invention relates to a novel synergistic herbal composition for the treatment of gastric ulcer, a method for preparing said synergistic herbal composition and a process for the treatment of gastric ulcer using said composition and more particularly, the ... | 02/15/2005 |
| 6780881 | Freeze-dried pantoprazole preparation and pantoprazole injection Lyophilized pantoprazole preparations which are obtainable by freeze-drying of an aqueous solution of pantoprazole, ethylenediamine tetraacetic acid and/or a suitable salt thereof, and sodium hydroxide and/or sodium carbonate are disclosed. The preparations have adv... | 08/24/2004 |
| 6767559 | DASC compositions, process for preparing same and suspensions containing same The present invention provides DASC compositions, which upon introduction into aqueous solutions, form stable, non-gritty suspensions. The present invention also provides stable, non-gritty suspensions comprising the DASC compositions of the present invention admixe... | 07/27/2004 |
| 6638523 | Method of treating ulcers A method of treating ulcers comprising administering an effective amount of carnosic acid and/or carnosol or a plant extract containing carnosic acid and/or carnosol as an effective ingredient to a subject having such ulcers.... | 10/28/2003 |
| 6593339 | Use of compounds as antibacterial agents The present invention discloses a new use of NO-releasing NSAIDs, especially NO-releasing NSAIDs of the formula I, or a pharmaceutically acceptable salt or enantiomer thereof, for the manufacture of a medicament for the treatment of bacterial infections, ... | 07/15/2003 |
| 6555534 | Method and compositions for the control or eradication of Helicobacter pylori The use of 4,4-methylenebis (tetrahydro-1,2-4-thiadiazine-1,1 -dioxide) in the eradication and control of the microorganism Helicobacter pylori in humans is disclosed.... | 04/29/2003 |
| 6498171 | Hydroxyomeprazole compositions Methods and compositions are disclosed utilizing hydroxyomeprazole for the treatment of ulcers in humans. Hydroxyomeprazole exhibits a lessened liability toward drug-drug interactions than omeprazole and a more predictable dosing regimen than omeprazole. ... | 12/24/2002 |
| 6489317 | Method for eradication of Helicobacter pylori The invention provides methods for the treatment and/or prevention of recurrence of a gastrointestinal disorder associated with Helicobacter pylori in a patient requiring said treatment and/or prevention, which comprise administering to the patient a ther... | 12/03/2002 |
| 6479041 | Method for producing aqueous emulsions or suspensions A method for producing aqueous emulsions or suspensions is described, in which a liquid phase is added to a supply tank, which is connected to a homogenizer having a stator, a rotor mounted rotatably in the stator and an additional connection, through whi... | 11/12/2002 |
| 6471955 | Ph-selective delivery system using crosslinked polymeric resins as vehicles This invention provides a method of preparing a polymeric delivery system for active ingredients having enhanced site specific release performance characteristics. The delivery system is formed either by attaching the active ingredient to a linker through... | 10/29/2002 |
| 6444232 | DASC compositions, process for preparing same and suspensions containing same The present invention provides DASC compositions, which upon introduction into aqueous solutions, form stable, non-gritty suspensions. The present invention also provides stable, non-gritty suspensions comprising the DASC compositions of the present inven... | 09/03/2002 |
| 6420435 | Method for treating gastrointestinal disorders Methods of treating gastrointestinal disorders (e.g. heart bum, GERD, and gastric indigestion) comprising orally administering therapeutically effective amounts of limonene are described herein.... | 07/16/2002 |
| 6420436 | Imaging contrast media and methods of use This invention relates to a non-aqueous fluorocarbon composition for use in magnetic resonance imaging (MRI) or radiographic imaging (X-ray or computed tomography), particularly imaging of the gastrointestinal (GI) tract; an improved fluorocarbon composit... | 07/16/2002 |
| 6395307 | Pourable alginate compositions An aqueous pourable liquid composition comprising a high concentration of sodium alginate and an alkali metal bicarbonate, wherein the sodium alginate has an average mannuronic acid residue to guluronic acid residue ratio of at least 0.6:1. In addition, a... | 05/28/2002 |
| 6379651 | Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases The invention relates to concomitant treatment with bismuth compounds, other antibacterial compounds, and/or antibiotics in oral-topical and peroral dosage forms to eradicate H. pylori from its niches both in the dental plaque and in the gastric mucosa in... | 04/30/2002 |
| 6380234 | Stabilized pharmaceutical composition and its production The pharmaceutical composition of the invention, which comprises a benzimidazole compound of the formula ##STR1## wherein R1 is hydrogen, alkyl, halogen, cyano, carboxy, carboalkoxy, carboalkoxyalkyl, carbamoyl, carbamoylalkyl, hydroxy, alkoxy,... | 04/30/2002 |
| 6365201 | Phytodrug for management of peptic ulcer and methods of preparing and using same A phytochemical composition for management of peptic ulcer conditions in humans is provided. The composition is a hot water extract of powdered Indigofera arrecta plant leaves. The extract may be prepared by contacting the powdered leaves with hot water f... | 04/02/2002 |
| 6258376 | Method of making chewing gum containing colloidal bismuth subcitrate The invention provides a method of making a chewing gum composition containing a water soluble bulk portion, a water insoluble chewing gum base portion, a flavoring agent, and bismuth-containing compounds. The invention provides a method of making a bismu... | 07/10/2001 |
| 6147053 | Combination containing growth factors and polyelectrolytes The invention relates to active substance combinations which consist of at least one polypeptide with the biological action of fibroblast growth factors and of at least one cationic polyelectrolyte. These combinations permit improved dosage of the FGF act... | 11/14/2000 |
| 6123962 | Process for producing stabilized pharmaceutical composition The pharmaceutical composition of the invention, which comprises a benzimidazole compound of the formula ##STR1## wherein R1 is hydrogen, alkyl, halogen, cyano, carboxy, carboalkoxy, carboalkoxyalkyl, carbamoyl, carbamoylalkyl, hydroxy, al... | 09/26/2000 |
| 6117868 | Treatment of gastrointestinal ulcers or gastritis caused by microbial infection A method and composition for the treatment of infectious gastrointestinal ulcer disease or infectious gastritis disease of microbially infected gastrointestinal tissue in a mammal involves administration of an antimicrobial amount of an antimicrobial medi... | 09/12/2000 |
| 6110891 | Lectin compositions and uses thereof This invention provides methods for: the control of mucosal cell proliferation; the reduction and/or treatment of damage caused by a cell-damaging agent; and for the reduction and/or treatment of a metabolic disorder. The methods comprise administering to... | 08/29/2000 |
| 6110506 | DASC compositions, process for preparing same and suspensions containing same The present invention provides DASC compositions, which upon introduction into aqueous solutions, form stable, non-gritty suspensions. The present invention also provides stable, non-gritty suspensions comprising the DASC compositions of the present inven... | 08/29/2000 |
| 6086882 | Phytodrug for management of peptic ulcer and methods of preparing and using same A phytochemical composition for management of peptic ulcer conditions in humans is provided. The composition is a hot water extract of powdered Indigofera arrecta plant leaves. The extract may be prepared by contacting the powdered leaves with hot water f... | 07/11/2000 |
| 6083509 | Phytodrug for management of peptic ulcer and methods of preparing and using same A phytochemical composition for management of peptic ulcer conditions in humans is provided. The composition is a hot water extract of powdered Indigofera arrecta plant leaves. The extract may be prepared by contacting the powdered leaves with hot water f... | 07/04/2000 |
| 6048552 | DASC compositions, process for preparing same and suspensions containing same The present invention provides DASC compositions, which upon introduction into aqueous solutions, form stable, non-gritty suspensions. The present invention also provides stable, non-gritty suspensions comprising the DASC compositions of the present inven... | 04/11/2000 |
| 6043243 | Pyrrolidine derivative, anti-ulcer drug, and antibacterial drug A pyrrolidine derivative or a salt thereof expressed by the following formula 1: ##STR1## wherein R1 is an alkenyl group; R2 is a lower alkoxy group or a halogen atom; R3 is a lower alkyl group; X is a group expressed... | 03/28/2000 |
| 6013680 | Digestive enzyme-containing medicament To provide a medicament that can be used as a drug for the effective treatment of gastric ulcers, duodenal ulcers and like diseases of the digestive tract. The medicament comprises a combination of at least one agent selected from the group consisting of ... | 01/11/2000 |
| 6013674 | Cell adhesion inhibitors This invention provides novel indenone derivatives, their pharmaceutical formulations and their use for the inhibition of leukocyte adherence to cells.... | 01/11/2000 |
| 5935998 | Use of all allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection or associated diseases Use of compounds of formula (I), wherein R has various significances, in free base form or in pharmaceutically acceptable salt form, as agents against H. pylori infection and associated diseases.... | 08/10/1999 |
| 5919824 | Aminophenol derivatives Aminophenol derivatives represented by the following formula (1): ##STR1## wherein X is O or S; A is alkylene, R1 is phenyl, etc., R2 and R3 are H or alkyl; R4 is substituted carbamoylalkyl, etc.; R5 | 07/06/1999 |
| 5914135 | Liquid antacid compositions Calcium carbonate liquid antacid compositions containing one or more pH adjusting agents to maintain the pH above 9.0, preferably above 9.5. The resultant antacid liquid possesses superior resistance to microbial attack and enhanced taste properties.... | 06/22/1999 |
| 5900413 | Treatment of H. pylori infections An infection with Helicobacter may successfully be treated with a compound of the formula ##STR1## wherein R1 is hydrogen or methyl and R2 is hydrogen or L-alanine-L-alanyl, and the pharmaceutically acceptable acid additive ... | 05/04/1999 |
| 5885960 | Method of treatment comprising administering a combination comprising FGF and polyelectrolytes The invention relates to active substance combinations which consist of at least one polypeptide with the biological action of fibroblast growth factors and of at least one cationic polyelectrolyte. These combinations permit improved dosage of the FGF act... | 03/23/1999 |
| 5879708 | Stabilized pharmaceutical composition The pharmaceutical composition of the invention, which comprises a benzimidazole compound of the formula ##STR1## wherein R1 is hydrogen, alkyl, halogen, cyano, carboxy, carboalkoxy, carboalkoxyalkyl, carbamoyl, carbamoylalkyl, hydroxy, al... | 03/09/1999 |
| 5877192 | Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole A method for treatment of gastric acid related diseases by inhibition of gastric acid secretion comprising administering to a mammal in need of treatment a therapeutically effective amount of the (-)-enantiomer of 5-methoxy-2-(4-methoxy-3,5-dimethyl-2... | 03/02/1999 |
| 5871774 | Drug units and methods for use Medical materials for use in treating maladies in living beings, such as ulcers and other conditions of the digestive tract. In one form, a container is provided for a medication which container also contains an adhesive material which is operatively rele... | 02/16/1999 |
